Novartis

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
104,323
Employees104,323
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
104,323
Employees104,323

NVS Key Statistics

Market cap
215.69B
Market cap215.69B
Price-Earnings ratio
9.48
Price-Earnings ratio9.48
Dividend yield
2.33
Dividend yield2.33
Average volume
2.02M
Average volume2.02M
High today
$91.30
High today$91.30
Low today
$89.42
Low today$89.42
Open price
$90.98
Open price$90.98
Volume
2.67M
Volume2.67M
52 Week high
$94.26
52 Week high$94.26
52 Week low
$74.09
52 Week low$74.09

NVS News

Benzinga 2d
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering

In this article: Sandoz , a generic pharmaceuticals and biosimilar unit of Novartis AG (NYSE: NVS), has agreed to acquire worldwide product rights for systemic...

Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Yahoo Finance 3d
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio - Yahoo Finance

Sandoz plans to acquire worldwide product rights for Mycamine ® (micafungin sodium) from Astellas Acquiring leading global echinocandin, one of three major ant...

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio - Yahoo Finance
Yahoo Finance 4d
Those who invested in Novartis a year ago are up 15% - Yahoo Finance

The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better than average stocks (as part of a divers...

Those who invested in Novartis a year ago are up 15% - Yahoo Finance

Analyst ratings

56%

of 27 ratings
Buy
33.3%
Hold
55.6%
Sell
11.1%

NVS Earnings

$0.00
$0.57
$1.14
$1.71
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
$1.39 per share
Estimated$1.39 per share
Actual
Available Feb 1, Pre-Market
ActualAvailable Feb 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.